Lars Rönnblom

Active 1990–2025

123
Papers
18,559
Citations
76
h-index
115
i10-index

Citations

Citations per year for Lars Rönnblom1982: 1 citations1991: 3 citations1992: 1 citations1993: 2 citations1994: 3 citations1995: 2 citations1997: 2 citations1998: 3 citations1999: 7 citations2000: 9 citations2001: 30 citations2002: 33 citations2003: 84 citations2004: 77 citations2005: 110 citations2006: 132 citations2007: 170 citations2008: 215 citations2009: 231 citations2010: 275 citations2011: 293 citations2012: 236 citations2013: 193 citations2014: 129 citations2015: 192 citations2016: 208 citations2017: 187 citations2018: 183 citations2019: 682 citations2020: 576 citations2021: 685 citations2022: 639 citations2023: 442 citations2024: 689 citations2025: 262 citations2026: 6 citations1983–1990: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,936 citing papers, 24.8% of this breakdownChina: 730 citing papers, 9.4% of this breakdownUnited Kingdom: 616 citing papers, 7.9% of this breakdownSweden: 488 citing papers, 6.2% of this breakdownGermany: 435 citing papers, 5.6% of this breakdownFrance: 310 citing papers, 4% of this breakdownItaly: 288 citing papers, 3.7% of this breakdownJapan: 277 citing papers, 3.5% of this breakdownNetherlands: 265 citing papers, 3.4% of this breakdownCanada: 226 citing papers, 2.9% of this breakdownSpain: 204 citing papers, 2.6% of this breakdownAustralia: 192 citing papers, 2.5% of this breakdown
0%24.8%Other 23.5%

Fields

  • Medicine55.1%
  • Immunology and Microbiology23.3%
  • Biochemistry, Genetics and Molecular Biology19.5%
  • Neuroscience0.8%
  • Dentistry0.2%
  • Computer Science0.2%
  • Other0.9%

Topics

  • Systemic Lupus Erythematosus Research12%
  • T-cell and B-cell Immunology7%
  • Immune Cell Function and Interaction4.6%
  • interferon and immune responses3.2%
  • Immune Response and Inflammation3.1%
  • Cytokine Signaling Pathways and Interactions2.8%
  • Other67.3%

Coauthors

All papers

Open in search
  1. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 1,094

  2. Interferon pathway in SLE: one key to unlocking the mystery of the disease

    Authors: , - Lupus Science & Medicine 2019 cited by 350

  3. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristine E. Lynch, Scott L. DuVall, Helene Garcon, Lauren O. Thomann, Jin Zhou, Bryan R. Gorman, Jennifer E. Huffman, Christopher J. O’Donnell, Philip S. Tsao, Jean C. Beckham, Saiju Pyarajan, Sumitra Muralidhar, Grant D. Huang, Rachel Ramoni, Pedro Beltrão, John Danesh, Adriana M. Hung, Kyong‐Mi Chang, Yan V. Sun, Jacob Joseph, Andrew R. Leach, Todd L. Edwards, Kelly Cho, J. Michael Gaziano, Adam S. Butterworth, Juan P. Casas, VA Million Veteran Program COVID-19 Science Initiative - Nature Medicine 2021 cited by 247

  4. Transancestral mapping and genetic load in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey C. Edberg, Emõke Endreffy, Jorge Antonio Esquivel‐Valerio, Paul R. Fortin, Barry I. Freedman, Johan Frostegård, Mercedes García, Ignacio García‐De La Torre, Gary S. Gilkeson, Dafna D. Gladman, Iva Gunnarsson, Joel M. Guthridge, Jennifer L. Huggins, Judith A. James, Cees G. M. Kallenberg, Diane L. Kamen, David R. Karp, Kenneth M. Kaufman, Leah C. Kottyan, László Kovács, Helle Laustrup, Bernard Lauwerys, Quan‐Zhen Li, Marco A. Maradiaga‐Ceceña, Javier Martı́n, Joseph M. McCune, David R. McWilliams, Joan T. Merrill, Pedro C. Miranda, J. F. Moctezuma, Swapan K. Nath, Timothy B. Niewold, Lorena Orozco, Norberto Ortego‐Centeno, Michelle Petri, Christian A. Pineau, Bernardo A. Pons‐Estel, Janet Pope, Prithvi Raj, Rosalind Ramsey‐Goldman, John D. Reveille, Laurie Russell, José Mario Sabio, Carlos A. Aguilar‐Salinas, Hugo R. Scherbarth, R Scorza, Michael F. Seldin, Christopher Sjöwall, Elisabet Svenungsson, Susan D. Thompson, Sergio Toloza, Lennart Truedsson, Teresa Tusié‐Luna, Carlos Vasconcelos, Luis M. Vilá, Daniel J. Wallace, Michael H. Weisman, Joan Wither, Tushar Bhangale, Jorge R. Oksenberg, John D. Rioux, Peter K. Gregersen, Ann‐Christine Syvänen, Lars Rönnblom, Lindsey A. Criswell, Chaim O. Jacob, Kathy L. Sivils, Betty P. Tsao, Laura E. Schanberg, Timothy W. Behrens and 8 more - Nature Communications 2017 cited by 437

  5. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Chodosh, Rajaram Gopalakrishnan, Kimberly S Hefner, J. Graeme Houston, Andrew Huang, Pamela Hughes, David M. Lewis, Lida Radfar, Michael D. Rohrer, Donald U. Stone, Jonathan D. Wren, Timothy J. Vyse, Patrick M. Gaffney, Judith A. James, Roald Omdal, Marie Wahren‐Herlenius, Gabor G Illei, Torsten Witte, Roland Jonsson, Maureen Rischmueller, Lars Rönnblom, Gunnel Nordmark, Wan‐Fai Ng, Xavier Mariette, Juan‐Manuel Anaya, Nelson L. Rhodus, Barbara M Segal, R. Hal Scofield, Courtney G. Montgomery, John B. Harley, Kathy L Sivils - Nature Genetics 2013 cited by 522

  6. Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. M. Stolarczyk, Kimberly E. Taylor, María Teruel, Elke Theander, Swamy Venuturupalli, Daniel J. Wallace, Kiely Grundahl, Kimberly S Hefner, Lida Radfar, David M. Lewis, Donald U. Stone, C. Erick Kaufman, Michael T. Brennan, Joel M. Guthridge, Judith A. James, R. Hal Scofield, Patrick M. Gaffney, Lindsey A. Criswell, Roland Jonsson, Per Eriksson, Simon Bowman, Roald Omdal, Lars Rönnblom, Blake M. Warner, Maureen Rischmueller, Torsten Witte, A. Darise Farris, Xavier Mariette, Marta E. Alarcón‐Riquelme, Caroline H. Shiboski, Marie Wahren‐Herlenius, Wan‐Fai Ng, UK Primary Sjögren’s Syndrome Registry, Kathy L. Sivils, Indra Adrianto, Gunnel Nordmark, Christopher J. Lessard - Nature Communications 2022 cited by 110

  7. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Genome biology 2013 cited by 405

  8. A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus

    Authors: , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 144

  9. Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 917

  10. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael F. Seldin, Lars Rönnblom, Lindsey A. Criswell, Ann-Christine Syvänen, Timothy W. Behrens, Robert Graham - Nature Genetics 2009 cited by 809

  11. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 143

  12. Induction of interferon‐α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG

    Authors: , , , , - Arthritis & Rheumatism 2004 cited by 551

  13. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 215

  14. Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 75

  15. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosus

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2011 cited by 124

  16. Three functional variants of IFN regulatory factor 5 ( IRF5 ) define risk and protective haplotypes for human lupus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 456

  17. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus

    Authors: , , , , , , , , - PLoS Genetics 2011 cited by 332

  18. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yong Cui, Timothy J. Vyse - Nature Genetics 2016 cited by 328

  19. Type I interferon system activation and association with disease manifestations in systemic sclerosis

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 196

  20. Sex differences in clinical presentation of systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , - Biology of Sex Differences 2019 cited by 126

  21. Role of interferons in SLE

    Authors: , - Best Practice & Research Clinical Rheumatology 2017 cited by 124

  22. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Journal of Human Genetics 2012 cited by 123

  23. Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

    Authors: , , , , , , , , , , , , , , , , , - ACR Open Rheumatology 2021 cited by 60

  24. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

    Authors: , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 40